Steven Cohen Atai Life Sciences N.V. Transaction History

Point72 Asset Management, L.P.

  • $36 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$1.44 - $2.19 $55,707 - $84,722
-38,686 Reduced 80.38%
9,444 $16,000
Q1 2023

May 15, 2023
SELL
$1.17 - $2.7 $143,340 - $330,785
-122,513 Reduced 71.79%
48,130 $87,000
Q4 2022

Feb 14, 2023
BUY
$2.38 - $3.55 $406,130 - $605,782
170,643 New
170,643 $453,000

Others Institutions Holding ATAI

# of Institutions
97
Shares Held
12.8M
Call Options Held
9.2K
Put Options Held
118K
View Full List

About ATAI Life Sciences N.V.

ATAI Quotes by TradingView
  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $189M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email